id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3091-0003,FDA,FDA-2018-N-3091,Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal,Notice,Notice of Renewal,2022-12-13T05:00:00Z,2022,12,2022-12-13T05:00:00Z,,2022-12-13T16:40:16Z,2022-27014,0,0,0900006485532499